Use the Back button in your browser to see the other results of your search or to select another record.
P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy |
de Lazzari N, Gotte M, Kasper S, Meier E, Schuler M, Pogorzelski M, Siveke JT, Tewes M |
Supportive Care in Cancer 2024;32:437 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|